MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KL-04-0030085
Es Laetus Pharmaceuticals Private Limited
Es Laetus Pharmaceuticals Private Limited - trading in Kannur, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14.95 Lakh
▼ 4% YoY
Net profit · FY 2025
₹1,544
Net margin 0.1%
EBITDA · FY 2025
₹1.17 Lakh
EBITDA margin 7.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Es Laetus Pharmaceuticals Private Limited
Data last updated:
Es Laetus Pharmaceuticals Private Limited is a private limited company based in Kannur, Kerala, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 04 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U52609KL2016PTC046467. Its GSTIN is 32AAECE3764A1Z6 (Kerala).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mahesh Thikkal Rayaroth and Gireesh Mullikkot.
Its last annual general meeting (AGM) was held on 26 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kannur, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.95 Lakh, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹1,544 (net margin 0.1%) and EBITDA of ₹1.17 Lakh (EBITDA margin 7.8%). Revenue has declined at a compounded annual rate (CAGR) of 31% over three years and 26% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Es Laetus Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-04-0030085). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U52609KL2016PTC046467
Registration Number 046467
Incorporation Date 04 August 2016
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-04-0030085
Recognitions & Rankings of Es Laetus Pharmaceuticals
Contact details
Es Laetus Pharmaceuticals Private Limited's registered office is in Kannur, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRoom No. 51/2047, Super Bazar Bank Road, Kannur, Kerala, India – 670001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Es Laetus Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Es Laetus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Es Laetus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Es Laetus Pharmaceuticals Private Limited, buy the company report.
Financials of Es Laetus Pharmaceuticals Private Limited
FY 2025 filings availableEs Laetus Pharmaceuticals Private Limited reported revenue of ₹14.95 Lakh (down 4% YoY) for FY 2025.
Revenue · FY 2025
₹14.95 Lakh ▼ 4%
Net profit · FY 2025
₹1,544 margin 0.1%
EBITDA · FY 2025
₹1.17 Lakh margin 7.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 31%
5 years · compounded
▼ 26%
EBITDA CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 57%
5 years · compounded
▲ 10%
Revenue has declined at a compounded annual rate (CAGR) of 26% over five years, including a 4% fall in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,544 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Es Laetus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Es Laetus Pharmaceuticals Private Limited
Es Laetus Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Thikkal Rayaroth | Director | 27 Jan 2017 | 9 Years 9 Months | Current |
| Gireesh Mullikkot | Director | 04 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Es Laetus Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biomash Pharmaceuticals Private Limited | ₹14.98 Lakh (FY 2024) | -25.0% | Jaipur, Rajasthan, India | |||
| Es Laetus Pharmaceuticals Private Limitedthis company | ₹14.95 Lakh (FY 2025) | ₹1,544 | 0.1% | -4.0% | Kannur, Kerala, India | |
| Raptakind Pharmaceuticals Private Limited | ₹14.9 Lakh (FY 2024) | 17.0% | Muzaffarpur, Bihar, India | |||
| Dermace Pharmaceuticals Private Limited | ₹14.86 Lakh (FY 2025) | -32.0% | Sikandarpur, Uttar Pradesh, India | |||
| Fyzomax Pharmaceuticals Private Limited | ₹14.85 Lakh (FY 2025) | -6.0% | Delhi, India |
To see the full peer comparison of Es Laetus Pharmaceuticals Private Limited, buy the company report.
Auditor
Es Laetus Pharmaceuticals Private Limited is audited by SANKAR & MOORTHY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANKAR & MOORTHY | FY 2017 | 003575S |
Shareholding
The shareholding of Es Laetus Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Es Laetus Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jul 2023 | 100782927 | Dhanlaxmi Bank Limited | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Es Laetus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Es Laetus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Es Laetus Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAECE3764A1Z6 | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Es Laetus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Es Laetus Pharmaceuticals Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Lijesh Pillavayal Veetu ceased to be Director on 20 Oct 2021.
AGM
Es Laetus Pharmaceuticals Private Limited last Annual general meeting of members was held on 26 Aug 2025 as per latest MCA records.
Filing
Es Laetus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge with Dhanlaxmi Bank Limited amounted to Rs. 10.00 Lakh with Charge ID 100782927 was registered on 31 Jul 2023.
Ceased
Lijesh Pillavayal Veetu ceased to be Director.
Appointed
Mahesh Thikkal Rayaroth was appointed as Director.
Appointed
Gireesh Mullikkot was appointed as Director.
Appointed
Lijesh Pillavayal Veetu was appointed as Director.
Incorporation
04 Aug 2016
Es Laetus Pharmaceuticals Private Limited was registered on 04 Aug 2016 with Roc Ernakulam & aged 10 years 2 months as per MCA records.
Frequently asked questions
Es Laetus Pharmaceuticals is an active private limited company based in Kannur, Kerala, India. The company works in other wholesale, within the trading industry. It was incorporated on 04 August 2016 (10+ years old) and is registered under CIN U52609KL2016PTC046467.
Es Laetus Pharmaceuticals has 2 current directors:
- Mahesh Thikkal Rayaroth - Director
- Gireesh Mullikkot - Director
The latest financial statements of Es Laetus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 August 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Es Laetus Pharmaceuticals is 32AAECE3764A1Z6, registered in Kerala.
The CIN (Corporate Identification Number) of Es Laetus Pharmaceuticals is U52609KL2016PTC046467. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Es Laetus Pharmaceuticals was incorporated on 04 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Es Laetus Pharmaceuticals by revenue are Biomash Pharmaceuticals Private Limited, Raptakind Pharmaceuticals Private Limited, Dermace Pharmaceuticals Private Limited, Fyzomax Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Lijesh Pillavayal Veetu ceased to be Director on 20 Oct 2021. Mahesh Thikkal Rayaroth was appointed as Director on 27 Jan 2017. Gireesh Mullikkot was appointed as Director on 04 Aug 2016. Es Laetus Pharmaceuticals has 4 board changes on record in total.
Yes, Es Laetus Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-04-0030085).
The registered office of Es Laetus Pharmaceuticals is at Room No. 512047, Super Bazar Bank Road, Kannur, Kerala, India – 670001.
Es Laetus Pharmaceuticals operates in the trading industry, in the other wholesale segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages